Invicta Diagnostic Limited (NSE:INVICTA)

India · Delayed Price · Currency is INR

69.00

+1.00 (1.47%)

At close: Sep 10, 2026

Market Cap	854.89M
Revenue (ttm)	330.42M +382.9%
Net Income	49.06M
EPS	4.90
Shares Out	12.57M
PE Ratio	13.88
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	9,600
Open	68.05
Previous Close	68.00
Day's Range	68.05 - 70.00
52-Week Range	58.10 - 105.00
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 17, 2026

About Invicta Diagnostic

Invicta Diagnostic Limited owns and operates diagnostic centers under the PC Diagnostics brand name in India. It provides pathology and radiology testing services, such as imaging, pathology/clinical laboratory, and tele-radiology; cytogenetics and high-end molecular diagnostic tests; X-rays and ultrasounds; and computerized tomography (CT), magnetic resonance imaging, and positron emission tomography CT scans. The company also offers value-added services, including home collection of specimens and house calls, and various delivery or access mo... [Read more]

Industry Medical Laboratories

Founded 2016

Employees 113

Stock Exchange National Stock Exchange of India

Ticker Symbol INVICTA

Full Company Profile

Financial Performance

In fiscal year 2026, Invicta Diagnostic's revenue was 330.42 million, an increase of 9.48% compared to the previous year's 301.81 million. Earnings were 49.06 million, an increase of 0.30%.

Financial Statements